Global Pharmaceuticals & Biotech Big Green Snowflakes

BioRestorative Therapies

Market Cap: US$12.8m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

Cadrenal Therapeutics

Market Cap: US$27.1m

Operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions.

Palisade Bio

Market Cap: US$5.7m

A clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.

Avalo Therapeutics

Market Cap: US$152.6m

A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.

Molecure

Market Cap: zł130.9m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland.

ESSA Pharma

Market Cap: US$11.0m

A clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.

Acurx Pharmaceuticals

Market Cap: US$6.5m

A clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States.

Summit Therapeutics

Market Cap: US$19.3b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

NeuroSense Therapeutics

Market Cap: US$29.0m

A clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally.

Teva Pharmaceutical Industries

Market Cap: US$21.7b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Austar Lifesciences

Market Cap: HK$604.8m

An investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.

Syncom Formulations (India)

Market Cap: ₹16.2b

Manufactures, markets, and sells pharmaceutical formulation products in India and internationally.

Kimia Biosciences

Market Cap: ₹1.6b

Manufactures and sells active pharmaceutical ingredients (APIs) in India.

Antibiotice

Market Cap: RON 1.6b

Produces and sells medicinal products in Romania and internationally.

Aroa Biosurgery

Market Cap: AU$232.9m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

Kontafarma China Holdings

Market Cap: HK$162.1m

An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally.

Murae Organisor

Market Cap: ₹1.0b

Engages in the manufacture, marketing, trading, and distribution of a range of pharmaceutical formulation products in India and internationally.

Ascletis Pharma

Market Cap: HK$14.0b

A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.

Coral Laboratories

Market Cap: ₹1.8b

Manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally.

Beryl Drugs

Market Cap: ₹122.3m

Engages in the manufacture and marketing of various branded and generic pharmaceutical formulations in India.

CSPC Pharmaceutical Group

Market Cap: HK$127.1b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Biofrontera

Market Cap: US$9.0m

A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Adagene

Market Cap: US$103.7m

A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.

Oxford Biomedica

Market Cap: UK£709.1m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Vistagen Therapeutics

Market Cap: US$108.9m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders.

Medivir

Market Cap: SEK 221.9m

A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally.

Climb Bio

Market Cap: US$162.0m

A clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases.

Corvus Pharmaceuticals

Market Cap: US$459.0m

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

Galderma Group

Market Cap: CHF 34.2b

Operates as a dermatology company worldwide.

Nanologica

Market Cap: SEK 118.9m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.

Corline Biomedical

Market Cap: SEK 364.9m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

IXICO

Market Cap: UK£11.0m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

Azitra

Market Cap: US$3.0m

An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

Corbus Pharmaceuticals Holdings

Market Cap: US$120.8m

A biopharmaceutical company, develops products to defeat serious illness.

Marinomed Biotech

Market Cap: €36.1m

A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.

Gerresheimer

Market Cap: €1.5b

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.